Page last updated: 2024-08-24

1,2-dipalmitoylphosphatidylglycerol and Experimental Hepatoma

1,2-dipalmitoylphosphatidylglycerol has been researched along with Experimental Hepatoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jaromin, A; Kaczmarek, L; Kozubek, A; Malicka-Blaszkiewicz, M; Peczynska-Czoch, W; Suchoszek-Lukaniuk, K1

Other Studies

1 other study(ies) available for 1,2-dipalmitoylphosphatidylglycerol and Experimental Hepatoma

ArticleYear
Liposomal formulation of DIMIQ, potential antitumor indolo[2,3-b]quinoline agent and its cytotoxicity on hepatoma Morris 5123 cells.
    Drug delivery, 2008, Volume: 15, Issue:1

    Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Antineoplastic Agents; Carbolines; Cell Shape; Cell Survival; Chemistry, Pharmaceutical; Dimyristoylphosphatidylcholine; Dose-Response Relationship, Drug; Drug Compounding; Glycerophospholipids; Hemolysis; Hydrogen-Ion Concentration; Liposomes; Liver Neoplasms, Experimental; Particle Size; Phosphatidylglycerols; Rats; Rats, Inbred BUF; Sheep; Tumor Cells, Cultured

2008